1. Guo, Gao, Gong, Ke, Beckley, Nicole, Zhao, Dawen, Habib, Amyn A. 2022. EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation. In Nature cell biology, 24, 1291-1305. doi:10.1038/s41556-022-00962-4. https://pubmed.ncbi.nlm.nih.gov/35915159/
2. Cosgrove, Michael S, Ding, Ye, Rennie, William A, Lane, Michael J, Hanes, Steven D. 2012. The Bin3 RNA methyltransferase targets 7SK RNA to control transcription and translation. In Wiley interdisciplinary reviews. RNA, 3, 633-47. doi:10.1002/wrna.1123. https://pubmed.ncbi.nlm.nih.gov/22740346/
3. Li, Daohang, Deng, Weiming, Huang, Guozheng, Xiao, Xin. . Bridging Integrator 3 (BIN3) Downregulation Predicts a Poor Prognosis in Patients with Esophagus Carcinoma: A Study based on TCGA Data. In Combinatorial chemistry & high throughput screening, 26, 1974-1989. doi:10.2174/1386207326666221205101815. https://pubmed.ncbi.nlm.nih.gov/36475339/
4. Routhier, E L, Burn, T C, Abbaszade, I, Albright, C F, Prendergast, G C. 2001. Human BIN3 complements the F-actin localization defects caused by loss of Hob3p, the fission yeast homolog of Rvs161p. In The Journal of biological chemistry, 276, 21670-7. doi:. https://pubmed.ncbi.nlm.nih.gov/11274158/
5. Prendergast, George C, Muller, Alexander J, Ramalingam, Arivudanambi, Chang, Mee Young. 2008. BAR the door: cancer suppression by amphiphysin-like genes. In Biochimica et biophysica acta, 1795, 25-36. doi:10.1016/j.bbcan.2008.09.001. https://pubmed.ncbi.nlm.nih.gov/18930786/